Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neuralgia × Gabapentin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 4 Pain 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Neuralgia 1 Neoplasms 1 Mucositis 1 Lung Neoplasms 1 Hot Flashes 1 Breast Neoplasms 1 Abnormalities, Radiation-Induced 1

Interventions

Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Paclitaxel 1 Oxaliplatin 1 Geritol 1 Gabapentin 1 Drug Therapy 1 Docetaxel 1 Cisplatin 1 Bupivacaine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03747562 2024-09-19

stREnGTH

University Hospital, Ghent

Phase 3 Withdrawn

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡